ANTIDIABETIC MEDICATION COMPRISING DPP-4 INHIBITOR (LINAGLIPTIN) OPTIONALLY IN COMBINATION WITH OTHER ANTIDIABETIC

摘要

PROBLEM TO BE SOLVED: To provide a medication and/or method for preventing, slowing progression of, delaying or treating a metabolic disorder, in particular of type 2 diabetes mellitus.SOLUTION: The invention relates to antidiabetic medications which are suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia, inter alia. In addition, the present invention relates to methods for preventing or treating of metabolic disorders and related conditions. The medication is a mono treatment with a DPP-4 inhibitor (preferably linagliptin) or a combination treatment with the DPP-4 inhibitor and a second and/or third antidiabetic.SELECTED DRAWING: None